Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.
The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback